Lipoprotein disorders overview: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 14: | Line 14: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Cardiology]] | |||
[[Category:Lipid disorders]] | |||
[[Category:Mature chapter]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Metabolic disorders]] |
Revision as of 02:52, 21 September 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Lipoprotein Disorders Microchapters |
Overview
Hyperlipidemia, hyperlipoproteinemia or dyslipidemia is the presence of raised or abnormal levels of lipids and/or lipoproteins in the blood. Lipids (fatty molecules) are transported in a protein capsule, and the density of the lipids and type of protein determines the fate of the particle and its influence on metabolism.
Lipid and lipoprotein abnormalities are extremely common in the general population, and are regarded as a highly modifiable risk factor for cardiovascular disease due to the influence of cholesterol, one of the most clinically relevant lipid substances, on atherosclerosis. In addition, some forms may predispose to acute pancreatitis.